Housing conditions and the anxiolytic efficacy of buspirone:: the relationship between main and side effects

被引:33
作者
Haller, J [1 ]
Halász, J [1 ]
Makara, GB [1 ]
机构
[1] Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary
来源
BEHAVIOURAL PHARMACOLOGY | 2000年 / 11卷 / 05期
关键词
rat; anxiety; anxiolytic; buspirone; corticosterone; stress; locomotion; isolation;
D O I
10.1097/00008877-200008000-00006
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Serotonergic anxiolytics yield contradictory results both in the laboratory and clinically. In an attempt to investigate the cause of discrepancies, the anxiolytic effect of buspirone (0, 3 or 10 mg/kg, single treatment) was tested 1 h and 4 h after injection in rats In different housing conditions. At 1 h after drug administration, buspirone increased corticosterone production and decreased locomotor behaviour in both the elevated plus-maze and the social interaction tests. No anxiolytic-like effect was produced in either test. At 4 h after drug injection, no corticosterone or locomotor effects of buspirone were observed. In contrast, anxiolytic effects emerged in this phase, Open arm exploration and social investigation were increased in the plus-maze and social interaction test, respectively. In the plus-maze, the anxiolytic effect was significant in isolated animals only. In the social interaction test, the anxiolytic effect was stronger in isolated than in group-housed animals. When corticosterone secretion was inhibited by adrenalectomy, a full anxiolytic effect of buspirone was observed 1 h after drug administration. It appears that the side effects of buspirone have a shorter duration than the main anxiolytic effect. The buspirone-induced increase in corticosterone may have abolished the anxiolytic effects of the drug shortly after injection. Individual housing enhanced the anxiolytic efficacy of buspirone 4 h after administration. (C) 2000 Lippincott Williams & Wiikins.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 50 条
[1]   HANDLING HISTORY OF RATS MODIFIES BEHAVIORAL-EFFECTS OF DRUGS IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY [J].
ANDREWS, N ;
FILE, SE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (01) :109-112
[2]   5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS [J].
BARRETT, JE ;
VANOVER, KE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :1-12
[3]   BEHAVIORAL PHYSIOLOGY OF SEROTONERGIC AND STEROID-LIKE ANXIOLYTICS AS ANTISTRESS DRUGS [J].
BOHUS, B ;
KOOLHAAS, JM ;
KORTE, SM ;
BOUWS, GAH ;
EISENGA, W ;
SMIT, J .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1990, 14 (04) :529-534
[4]   DISPOSITION OF THE PSYCHOTROPIC-DRUGS BUSPIRONE, MJ-13805 AND PIRIBEDIL, AND OF THEIR COMMON ACTIVE METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE IN THE RAT [J].
CACCIA, S ;
FONG, MH ;
GUISO, G .
XENOBIOTICA, 1985, 15 (10) :835-844
[5]   1-(2-PYRIMIDINYL)-PIPERAZINE AS ACTIVE METABOLITE OF BUSPIRONE IN MAN AND RAT [J].
CACCIA, S ;
CONTI, I ;
VIGANO, G ;
GARATTINI, S .
PHARMACOLOGY, 1986, 33 (01) :46-51
[6]   Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze [J].
Cao, BJ ;
Rodgers, RJ .
NEUROPHARMACOLOGY, 1997, 36 (08) :1089-1097
[7]   On the elevated plus maze the anxiolytic like effects of the 5-HT1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635 [J].
Collinson, N ;
Dawson, GR .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :35-43
[8]  
COWEN PJ, 1990, J CLIN PSYCHOPHARM, V10, P21
[9]   Genetics of mouse behavior: Interactions with laboratory environment [J].
Crabbe, JC ;
Wahlsten, D ;
Dudek, BC .
SCIENCE, 1999, 284 (5420) :1670-1672
[10]  
CURRIE PJ, 1993, NEUROREPORT, V4, P1105